Skip to main content
SpringerLink
Log in

The enhancement of the subacute repeat dose toxicity test OECD TG 407 for the detection of endocrine active chemicals: comparison with toxicity tests of longer duration

  • Regulatory Toxicology
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

The OECD conventional 28-day repeat dose toxicity test (OECD TG 407) is widely employed in the initial hazard identification and characterization for commercial chemicals. The OECD has recently undertaken an international effort to “enhance” the conventional 28-day repeat dose toxicity test (OECD TG 407) in order to ensure that chemicals acting through (anti)estrogenic, (anti)androgenic, and (anti)thyroid mechanisms are identified. The enhancements include additional parameters based on the respective target organs from the male and female reproductive tracts, the thyroid, and circulating hormone levels. Ten chemicals with known endocrine modes of action and different potencies were administered using the “enhanced TG 407” test protocol to investigate the performance of this procedure. In the present evaluation, these “enhanced TG 407” protocol results, drawn from a report of the OECD validation studies, are compared to studies of the same or similar chemicals with longer and/or in utero exposures in order to evaluate the capability of the this “enhanced TG 407” in identifying the chemicals’ mode of action. The major conclusions that can be drawn from these comparisons are:

  1. 1.

    The “enhanced TG 407” will reliably identify chemicals with a strong to moderate potential to act through endocrine modes of action on the gonads and the thyroid. In addition, this test method gives a first indication for the dose-related potency.

  2. 2.

    Substances with a low potency for an endocrine mode of action, i.e., having only marginal effects in the most comprehensive in vivo studies such as multi-generation studies, may not elicit clear endocrine-related effects in the “enhanced TG 407”. In these cases, the primary or principal effects observed will be driven by other toxic actions of the test materials in the “enhanced TG 407”.

  3. 3.

    It may be concluded from the present database that prolongation of exposure from 28 days up to 90 days is unlikely to improve the chance of detecting an endocrine-mediated effect

  4. 4.

    A number of higher tier studies with in utero and pubertal exposure show that prenatally exposed rats may be more sensitive to exposures to compounds with very low estrogenic or antiandrogenic potential in some cases than young adult rats as used in the “enhanced TG 407”.

  5. 5.

    Overall, these comparisons support the use of the “enhanced TG407” for the detection of endocrine active chemicals. It is therefore recommended to fully accept the enhancements and include them in the test method for toxicological and regulatory use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Andrews P, Freyberger A, Hartmann E, Eiben R, Loof I, Schmidt U, Temerowski M, and Becka M (2001) Feasibility and potential gains of enhancing the subacute rat study protocol (OECD test guideline no. 407) by additional parameters selected to determine endocrine modulation. A pre-validation study to determine endocrine-mediated effects of the antiandrogenic drud flutamide. Arch Toxicol 75:65–73

    Article  PubMed  CAS  Google Scholar 

  • Andrews P, Freyberger A, Hartmann E, Eiben R, Loof I, Schmidt U, Temerowski M, Folkerts A, Stahl B. and Kayser M (2002) Sensitive detection of the endocrine effects of the estrogen ethinylestradiol using a modified enhanced subacute rat study protocol (OECD Test Guideline no. 407). Arch Toxicol 76:194–202

    Article  PubMed  CAS  Google Scholar 

  • APERC (Alkylphenols & Ethoxylates Research Council) (2003) Three generation, endpoint specific evaluation of para-nonylphenol toxicity in rats. RTI USA Toxicol Sci (in press)

  • Aso S, Anai M, Noda S, Imatanaka N, Yamasaki K, Maekawa A (2000) Twenty-eight-day repeated dose toxicity studies for detection of weak endocrine dirupting effects od nonylphenol and atrazine in female rats. J Toxicol Pathol 13:13–20

    Article  CAS  Google Scholar 

  • Biegel LB, Flaws JA, Hirshfield AN, O’Connor JC, Elliot GS, Ladics GS, Silbergeld EK, van Pelt CS, Hurtt ME, Cook JC, Frame SR (1998) 90-day feeding and one-generation reproduction study in Crl:CD BR rats with 17β-estradiol. Toxicol Sci 44:116–142

    PubMed  CAS  Google Scholar 

  • Casanova M, You L, Gaido KW, Archibeque-Engle S, Janszen DB, Heck H d’A (1999) Developmental effects of dietary phytoestrogens in Sprague–Dawley rats and interactions of genistein and daidzein with rat estrogen receptors α and β in vitro. Toxicol Sci 51:236–244

    Article  PubMed  CAS  Google Scholar 

  • Chapin RE, Delaney J, Wang Y, Lanning L, Davis B, Collins B, Mintz N, Wolfe G (1999) The effects of 4-nonylphenol in rats: a multigeneration reproduction study. Toxicol Sci 52:80–91

    Article  PubMed  CAS  Google Scholar 

  • Cho SG, Kim JH, Kim DY, Lee YS, Kang KS (2003) Pre-validation study for OECD enhanced test guideline 407 protocol by gavage for 4 weeks using propylthiouracil and tamoxifen. Toxicol Lett 144:195–204

    Article  PubMed  CAS  Google Scholar 

  • Cunny HC, Mayes BA, Rosica KA, Trutter JA, van Miller JP (1997) Subchronic toxicity (90-day) study with para-nonylphenol in rats. Regul Toxicol Pharmacol 26:172–178

    Article  PubMed  CAS  Google Scholar 

  • Declos KB, Bucci TJ, Lomax LG, Latendresse JR, Warbritton A, Weis CC, Newbold RR (2001) Effects of dietary genistein exposure during development on male and female CD (Sprague–Dawley) rats. Reprod Toxicol 15:647–663

    Article  Google Scholar 

  • Declos KB, Weis CC, Olson G, Bucci TJ, Newbold RR (2003) A five generation reproductive toxicity assessment of the soy isoflavone genistein in CD Sprague–Dawley rats. Toxicol Sci 72(Suppl 1):76

    Google Scholar 

  • Fritz WA, Coward L, Wand J, Lamartiniere CA (1998) Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat Carcinogenesis 19:2151–2158

  • Gao Y, Short RV (1993) Use of an oestrogen, androgen or gestagen as a potential chemosterilant for control of rat and mouse populations. J Reprod Fertil 97:39–49

    Article  PubMed  CAS  Google Scholar 

  • Gill-Sharma MK, Balasinor N, Parte P (2001) Effect of intermittant treatment with tamoxifen on reproduction in male rats. Asian J Androl 3:115–119

    PubMed  CAS  Google Scholar 

  • Goldeye ES, Kehn LS, Rehnberg GL, Crofton KM (1995) Effects of developmental hypothyroidism on auditory and motor function in the rat. Toxicol Appl Pharmacol 135:67–76

    Article  Google Scholar 

  • Kang KS, Che JH, Lee YS (2002) Lack of adverse effects in the F1 offspring maternally exposed to genistein at human intake dose level. Food Chem Toxicol 40:43–51

    Article  PubMed  CAS  Google Scholar 

  • Kassim NM, McDonald SW, Reid O, Bennett NK, Gilmore DP, Payne AP (1997) The effects of pre- and postnatal exposure to the nonsteroidal antiandrogen flutamide on testis descent and morphology in the albino swiss rat. J Anat 190:577–588

    Article  PubMed  CAS  Google Scholar 

  • Kennel P, Pallen C, Barale-Thomas E, Espuna G, Bars R (2003) Tamoxifen: 28-day oral toxicity study in the rat based on the Enhanced OECD Test Guideline 407 to detect endocrine effects. Arch Toxicol 77:487–499

    Article  PubMed  CAS  Google Scholar 

  • Kornbrust D, Gillis B, Collins B, Goehl T, Gupta B, Schwetz B (1986) Effects of 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE) on lactation in rats. J Toxicol Environ Health 17:23–36

    Article  PubMed  CAS  Google Scholar 

  • Kunimatsu T, Yamada T, Miyata K, Yabushita S, Seki T, Okuno Y, Masuo M (2004) Evaluation for reliability and feasibility of the draft protocol for the enhanced rat 28-day subacute study (OECD Guideline 407) using androgen antagonist flutamide. Toxicology 200:77–89

    Article  PubMed  CAS  Google Scholar 

  • Levy JR, Faber KA, Ayyash L, Hughes CL (1995) The effect of prenatal exposure to the phytoestrogen genistein on sexual differentiation in rats. Proc Soc Exp Biol Med 208:60–66

    PubMed  CAS  Google Scholar 

  • Lewis RW, Brooks N, Milburn GM, Soames A, Stone S, Hall M, Ashby J (2003) The effects of the phytoestrogen genistein on the postnatal development of the rat. Toxicol Sci 71:74–83

    Article  PubMed  CAS  Google Scholar 

  • Loeffler IK, Peterson RE (1999) Interactive effects of TCDD and p,p’-DDE on male reproductive tract development in in utero and lactationally exposed rats. Toxicol Appl Pharmacol 154:28–39

    Article  PubMed  CAS  Google Scholar 

  • McClain RM, Wolz E, Davidovich A, Pfannkuch F, Edwards JA, Bausch J (2006) Acute, subchronic and chronic safety studies with genistein in rats Food Chem. Toxicol 44:56–80

    CAS  Google Scholar 

  • McIntyre BS, Barlow NJ, Foster PMD (2001) Androgen-mediated development in male rat offspring exposed to flutamide in utero: permanence and correlation of early postnatal changes in anogenital distance and nipple retention with malformations in androgen-dependent tissues. Toxicol Sci 62:236–249

    Article  PubMed  CAS  Google Scholar 

  • Mellert W, Deckardt K, Walter J, Gfatter S, van Ravenzwaay B (2003) Detection of endocrine-modulating effects of the antithyroid acting drug 6propyl-2-thiouracil in rats, based on the “Enhanced OECD Test Guideline 407”. Regul Toxicol Pharmacol 38:368–377

    Article  PubMed  CAS  Google Scholar 

  • Miyata K, Yabushita S, Sukata T, Sano M, Yoshino H, Nakanishi T, Okuno Y, Matsuo M (2002) Effects of perinatal exposure to flutamide on sex hormones and androgen-dependent organs in F1 male rats. J Toxicol Sci 27:19–33

    Article  PubMed  Google Scholar 

  • Mylchreest E, Sar M, Cattley RC, Foster PMD (1999) Disruption of androgen-regulated male reproductive development by Di(n-Butyl) Phthalate during late gestation in rats is different from flutamide. Toxicol Appl Pharmacol 156:81–95

    Article  PubMed  CAS  Google Scholar 

  • Nagao T, Wada K, Marumo H, Yoshimura S, Ono H (2001) Reproductive effects of nonylphenol in rats after gavage adminstation: a two-generation study. Reprod Toxicol 15:293–315

    Article  PubMed  CAS  Google Scholar 

  • Noda S, Muroi T, Takakura S, Sakamoto S, Takatsuki M, Yamasaki K, Tateyama S, Yamaguchi R (2005) Preliminary evaluation of an in utero-lactation assay using 6-npropyl-2-thiouracil. Arch Toxicol 79:414–421

    Article  PubMed  CAS  Google Scholar 

  • Odum J, Lefevre PA, Tinwell H, van Miller JP, Joiner RL, Chapin RE, Wallis NT, Ashby J (2002) Comparison of the developmental and reproductive toxicity of diethylstilbestrol administered to rats in utero, lactationally, preweaning, or postweaning. Toxicol Sci 68:147–163

    Article  PubMed  CAS  Google Scholar 

  • OECD (1995) Guideline for the testing of chemicals. TG 407. Repeated dose 28-day oral toxicity study in rodents. Adopted on 27th July 1995

  • OECD (1998) Report of the first meeting of the OECD Endocrine Disruptor Testing and Assessment Task Force (EDTA), 10th–11th March 1998, EV/MC/ChEM/RA(98)5

  • OECD (2000a) Status of work on the enhancement of test guideline 407. OECD document ENV/JM/TG/EDTA/M(2000)6

  • OECD (2000b) Summary record of the 4th meeting of the EDTA. OECD document ENV/JM/TG/EDTA/M(2000)2

  • OECD (2003) SIDS manual (Third Edition), 1997. OECD, Paris

  • Okahara A, Nomura A, Tanioka H, Sakamoto H, Yamashita K, Ikuse T (2000) Collaborative work to evaluate toxicity on male reproductive organs by repeated dose studies in rats. 5. Effects of repeated doses of flutamide for 2 and 4 weeks. J Toxicol Sci 25(Special issue):63–70

    PubMed  CAS  Google Scholar 

  • Okazaki K, Imazawa T, Nakamura H, Furukawa F, Nishikawa A, Hirose M (2002) A repeated 28-day oral dose toxicity study of 17α-methyltestosterone in rats, based on the “Enhanced OECD Test Guideline 407” for screening the endocrine disrupting chemicals. Arch Toxicol 75:635–642

    Article  PubMed  CAS  Google Scholar 

  • Okazaki K, Okazaki S, Nakamura H, Kitamura Y, Hatayama K, Wakabayashi S, Tsuda T, Katsumata T, Nishikawa A, Hirose M (2002) A repeated 28-day oral dose toxicity study of genistein in rats, based on the “Enhanced OECD Test Guideline 407” for screening endocrine-disrupting chemicals. Arch Toxicol 76:553–559

    Article  PubMed  CAS  Google Scholar 

  • Owens JW (2004) Draft final report of the validation of the enhanced test guideline 407 repeat dose 28-day oral toxicity study in laboratory rats. Unpublished OECD document

  • Richig JW, McCormick CG, Green JD (1987) CGS 18320B 13-week oral toxicity study in rats. Unpublished report of Ciba-Geigy Corporation, Summit

  • Sawaki M, Noda S, Muroi T, Mitoma H, Takakura S, Sakamoto S, Yamasaki K (2003a) Evaluation of an in utero lactational exposure protocol for detection of estrogenic effects of ethinyl estradiol on the offspring of rats: preliminary trial. Reprod Toxicol 17:335–343

    Article  CAS  Google Scholar 

  • Sawaki M, Noda S, Muroi T, Mitoma H, Takakura S, Sakamoto S, Yamasaki K (2003b) In Utero through lactational exposure to ethinyl estradiol induces cleft phallus and delayed ovarian dysfunction in the offspring. Toxicol Sci 75:402–411

    Article  CAS  Google Scholar 

  • Shigeru I, Masamichi I, Hiroyuki S, Takumi Y, Kota N (1993) A fertility study in male rats treated with flutamide. Oyo Yakuri (Pharmacometrics, Japanese) 45:187–199

    Google Scholar 

  • Toyoda K, Shibutani M, Tamura T, Koujitani T, Uneyama C, Hirose M (2000) Repeated dose (28 days) toxicity study of flutamide in rats, based on the dradt protocol for the “Enhanced OECD Test Guideline 407” for screening for endocrine-disrupting chemicals. Arch Toxicol 74:127–132

    Article  PubMed  CAS  Google Scholar 

  • Van der Schoot P (1992) Disturbed testicular descent in the rat after prenatal exposure to the antiandrogen flutamide. J Reprod Fert 96:483–496

    Article  CAS  Google Scholar 

  • Walker UJ, Nogues V (1994) Changes induced by treatment with aromatase inhibitors in testicular Leydig cells of rats and dogs. Exp Toxic Pathol 46:211–213

    CAS  Google Scholar 

  • Wason S, Pohlmeyer-Esch G, Pallen C, Palzzi X, Espuna G, and Bars R (2003) 17α-Methyltestosterone: 28-day oral toxicity study in the rat based on the “Enhanced OECD Test Guideline 407” to detect endocrine effects. Toxicology 192:119–137

    Article  PubMed  CAS  Google Scholar 

  • Weybridge (1996) European workshop on the impact of endocrine disruptors on human health and wildlife. Report of the proceedings December 2–4, 1996. Report EUR 175497

  • Wiesniewski AB, Klein SL, Lakshmanan Y, Gerhart JP (2003) Exposure to genistein during gestation and lactation demasculinizes the reproductive system in rats. J Urol 169:1582–1586

    Article  CAS  Google Scholar 

  • Wolfe GW, Kaiser LB, Chapin RE (1997) Final report of the reproductive toxicity of Tamoxifen Citrate (CAS No. 54965-24-1) administered by gavage to Sprague-Dawley rats. Study performed for the National Toxicology Program by R.O.W. Sciences, Inc. Gaithersburg, MD, USA. NTIS No. PB97199723

  • Wolfe GW, Pepperl S, Greenlaw J (2002) Two-generation reproduction toxicity study of propylthiouracil when administered to Sprague–Dawley rats in the drinking water. Study performed for the US Environmental Protection Agency by TherImmune Research Corporation, TRC Study No. 7244–601, Gaithersburg

  • Yamasaki K, Sawaki M, Noda S, Imatanaka N, Takatsuki M (2002a) Subacute oral toxicity study of ethinyl estradiol and bisphenol A, based on the draft protocol for the “Enhanced OECD Test Guideline no. 407”. Arch Toxicol 76:65–74

    Article  PubMed  CAS  Google Scholar 

  • Yamasaki K, Tago Y, Nagai K, Sawaki M, Noda S, Takatsuki M (2002b) Comparison of toxicity studies based on the draft protocol for the “Enhanced OECD Testguideline no. 407” and the research protocol of “Pubertal Development and Thyroid Function in Immature Male Rats” with 6n-propyl-2-thiouracil. Arch Toxicol 76:495–501

    Article  PubMed  CAS  Google Scholar 

  • Yamasaki K, Noda S, Muroi T, Mitoma H, Takakura S, Sakamoto S (2005a) Effects of in utero and lactational exposure to tamoxifen in SD rats. Toxicol Lett 156:289–296

    Article  PubMed  CAS  Google Scholar 

  • Yamasaki K, Noda S, Muroi T, Mitoma H, Takakura S, Sakamoto S (2005b) Effects of in utero and lactational exposure to flutamide in SD rats: comparison of the effects of administration periods. Toxicology 209:47–54

    Article  PubMed  CAS  Google Scholar 

  • You L, Casanova M, Arichibeque-Engle S, Sar M, Fan L, Heck H d’A (1998) Impaired male sexual development in perinatal Sprague–Dawley and Long Evans hooded rats exposed in utero and lactationally to p,p’-DDE. Toxicol Sci 45:162–173

    PubMed  CAS  Google Scholar 

  • You L, Brenneman KA, Heck H d’A (1999) In utero exposure to antiandrogens alters the responsiveness of the prostate to p,p’-DDE in adult rats and may induce prostatic inflammation. Toxicol Appl Pharmacol 161:258–266

    Article  PubMed  CAS  Google Scholar 

  • You L, Casanova M, Bartolucci EJ, Fryczynski MW, Dorman DC, Everitt JI, Gaido KW, Ross SM, Heck H d’A (2002) Combined effects of dietary phytoestrogen and synthetic endocrine-active compound on reproductive development in Sprague–Dawley rats: genistein and methoxychlor. Toxicol Sci 66:91–104

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors thankfully acknowledge the scientific support by the members of the Science Group of the “Endocrine Modular Steering Group (EMSG)” of CEFIC. They gratefully express their thanks to all involved in the OECD validation studies for the “enhanced TG 407”, specifically the test laboratories providing the data, the OECD Secretariat organising and coordinating all activities, CEFIC/EMSG for supporting the chemical repository, and Herman Köeter for steering the whole process.

Author information

Authors and Affiliations

  1. CinTox, Dr. Kausch Straße 6a, 67251, Freinsheim, Germany

    Heinz-Peter Gelbke

  2. Weimarer Straße 6, 64807, Dieburg, Germany

    Andreas Hofmann

  3. The Procter and Gamble Company, Central Product Safety, 538707, Cincinnati, OH, 45253, USA

    J. William Owens

  4. Bayer HealthCare AG, Pharmaceuticals, GGD – Molecular and Special Toxicology, 42096, Wuppertal, Germany

    Alexius Freyberger

Authors
  1. Heinz-Peter Gelbke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andreas Hofmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. William Owens
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alexius Freyberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Heinz-Peter Gelbke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gelbke, HP., Hofmann, A., Owens, J.W. et al. The enhancement of the subacute repeat dose toxicity test OECD TG 407 for the detection of endocrine active chemicals: comparison with toxicity tests of longer duration. Arch Toxicol 81, 227–250 (2007). https://doi.org/10.1007/s00204-006-0148-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-006-0148-3

Keywords

Search

Navigation